Kiniksa Pharmaceuticals (NASDAQ: KNSA) reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $0.27 by 11.11 percent. This is a 30.43 percent increase over earnings of $0.23 per share from the same period last year. The company reported quarterly sales of $243.600 million which beat the analyst consensus estimate of $225.457 million by 8.05 percent. This is a 55.36 percent increase over sales of $156.797 million the same period last year.